Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets.

作者信息

Aukrust P, Damås J K, Gullestad L, Frøland S S

出版信息

Clin Exp Immunol. 2001 Jun;124(3):343-5. doi: 10.1046/j.1365-2249.2001.01527.x.

DOI:10.1046/j.1365-2249.2001.01527.x

PMID:11472392

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1906089/

Abstract

摘要

相似文献

Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets.

Clin Exp Immunol. 2001 Jun;124(3):343-5. doi: 10.1046/j.1365-2249.2001.01527.x.

The biology of chemokines and their receptors.

Annu Rev Immunol. 2000;18:217-42. doi: 10.1146/annurev.immunol.18.1.217.

A burgeoning family of biological mediators: chemokines and chemokine receptors.

Arch Immunol Ther Exp (Warsz). 2000;48(3):143-50.

Chemokines and their receptors in rheumatoid arthritis: future targets?

Arthritis Rheum. 2005 Mar;52(3):710-21. doi: 10.1002/art.20932.

Questions about chemokine and chemokine receptor antagonism in renal inflammation.

Nephron Exp Nephrol. 2010;114(2):e33-8. doi: 10.1159/000254389. Epub 2009 Nov 3.

The chemokine network: a target in cancer biology?

Adv Drug Deliv Rev. 2006 Oct 1;58(8):962-74. doi: 10.1016/j.addr.2006.03.012. Epub 2006 Aug 15.

Chemokines.

ScientificWorldJournal. 2007 Feb 19;7:224-32. doi: 10.1100/tsw.2007.6.

Viral infections: impact on chemokines and chemokine receptors.

Viral Immunol. 2011 Dec;24(6):427-8. doi: 10.1089/vim.2011.ed.24.6.

Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis.

Mult Scler. 2000 Feb;6(1):3-13. doi: 10.1177/135245850000600103.

New drug targets in rheumatoid arthritis: focus on chemokines.

BioDrugs. 2004;18(3):181-7. doi: 10.2165/00063030-200418030-00004.

引用本文的文献

Reappraising the role of inflammation in heart failure.

Nat Rev Cardiol. 2020 May;17(5):269-285. doi: 10.1038/s41569-019-0315-x. Epub 2020 Jan 22.

CXCR4 Cardiac Specific Knockout Mice Develop a Progressive Cardiomyopathy.

Int J Mol Sci. 2019 May 8;20(9):2267. doi: 10.3390/ijms20092267.

Alteration of energy substrates and ROS production in diabetic cardiomyopathy.

Mediators Inflamm. 2013;2013:461967. doi: 10.1155/2013/461967. Epub 2013 Oct 31.

β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4.

J Cardiovasc Pharmacol. 2010 Nov;56(5):548-59. doi: 10.1097/FJC.0b013e3181f713fe.

Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H657-66. doi: 10.1152/ajpheart.00387.2008. Epub 2008 Jun 13.

Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha.

J Nucl Med. 2008 Jun;49(6):963-9. doi: 10.2967/jnumed.107.050054. Epub 2008 May 15.

CXCR4 modulates contractility in adult cardiac myocytes.

J Mol Cell Cardiol. 2006 Nov;41(5):834-44. doi: 10.1016/j.yjmcc.2006.08.008. Epub 2006 Sep 28.

Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.

J Mol Cell Cardiol. 2006 Jun;40(6):810-20. doi: 10.1016/j.yjmcc.2006.03.010. Epub 2006 May 5.

Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy.

Cardiovasc Res. 2006 Jul 1;71(1):139-48. doi: 10.1016/j.cardiores.2006.03.008. Epub 2006 Mar 16.

Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.

Am J Pathol. 2005 Aug;167(2):305-13. doi: 10.1016/S0002-9440(10)62976-8.

本文引用的文献

Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes.

Basic Res Cardiol. 2001 Jul;96(4):345-52. doi: 10.1007/s003950170042.

Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis.

Clin Exp Immunol. 2001 Jun;124(3):346-52. doi: 10.1046/j.1365-2249.2001.01510.x.

Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF).

Am Heart J. 2001 Mar;141(3):418-21. doi: 10.1067/mhj.2001.112785.

Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes.

J Am Coll Cardiol. 2001 Feb;37(2):485-91. doi: 10.1016/s0735-1097(00)01110-4.

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure.

Circulation. 2001 Jan 16;103(2):220-5. doi: 10.1161/01.cir.103.2.220.

A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.

Circulation. 2000 Oct 17;102(16):1944-9. doi: 10.1161/01.cir.102.16.1944.

Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure.

Circulation. 2000 Sep 12;102(11):1315-22. doi: 10.1161/01.cir.102.11.1315.

Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure.

Cardiovasc Res. 2000 Sep;47(4):778-87. doi: 10.1016/s0008-6363(00)00142-5.

Chemokines, leukocytes, and atherosclerosis.

J Lab Clin Med. 2000 Aug;136(2):87-92. doi: 10.1067/mlc.2000.108154.

Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart.

Lab Invest. 2000 Jul;80(7):1127-36. doi: 10.1038/labinvest.3780119.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验